Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | OSI-296 |
| Synonyms | |
| Therapy Description |
OSI-296 selectively inhibits MET and MST1R (RON), potentially resulting in decreased tumor cell proliferation (PMID: 23773865). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| OSI-296 | MET Inhibitor 59 RON Inhibitor 11 | OSI-296 selectively inhibits MET and MST1R (RON), potentially resulting in decreased tumor cell proliferation (PMID: 23773865). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| MST1R act mut | breast cancer | predicted - sensitive | OSI-296 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, OSI-296 inhibited tumor growth in breast cancer cell line xenograft models expressing a constitutively active short isoform of MST1R (RON) (PMID: 26289070). | 26289070 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|